About: Pharming Group N.V., a biopharmaceutical company, develops and commercializes protein replacement therapies and precision medicines for the treatment of rare diseases in the United States, Europe, and internationally. The company's lead product is RUCONEST, a recombinant C1 esterase inhibitor for the treatment of acute attacks in adult and adolescent patients with acute hereditary angioedema (HAE); and Joenja (leniolisib), an oral small molecule PI3K" inhibitor for the treatment of activated phosphoinositide 3-kinase delta syndrome. It also develops Joenja, an oral small molecule PI3K" inhibitor. It has a development collaboration and license agreement with Novartis. Pharming Group N.V. was incorporated in 1988 and is headquartered in Leiden, the Netherlands.
Sector: Healthcare
Industry: Biotechnology
Latest price: $9.53 (-1.24%)
PHAR NASDAQ Pharming Group NV
Pharming Group NV share price
PHAR price activity
Último preço
$ 9,530
Variação (24h)
-0,12 USD (-1,24%)
Volume
1.57K
Volume (média 4 sem.)
-
Abertura
$ 9,65
Variação do dia
$ 9,44 - $ 9,77
Fechamento anterior
$ 9,65
Último negócio
08 Oct, 4:11 pm GMT+0
Atrasado
08 Oct, 4:11 pm GMT+0
PHAR price performance
Atrasado
08 Oct, 4:11 pm GMT+0
quote.marketSignals